Oculomaxillofacial dysostosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1794Q75.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Oculomaxillofacial dysostosis, also known as oculo-maxillo-facial dysostosis or sometimes referred to in relation to similar conditions as a craniofacial dysostosis, is an extremely rare congenital condition that affects the development of the bones and structures of the face, eyes, and jaw. The condition is present at birth and involves abnormal formation of the bones around the eyes (orbital area), the upper jaw (maxilla), and other facial structures. Key features typically include underdevelopment of the cheekbones and upper jaw, abnormalities of the eyes such as small eyes (microphthalmia) or other eye malformations, and facial asymmetry. Some individuals may also have eyelid abnormalities, a small or recessed chin, and dental problems. Because this condition is so rare, the medical understanding of it is limited. Treatment is primarily supportive and symptom-based. Surgical correction of facial bone abnormalities and eye-related issues may be considered depending on severity. A team of specialists including craniofacial surgeons, ophthalmologists, and dentists typically work together to manage the various aspects of this condition. Early intervention and coordinated care can help improve quality of life and functional outcomes for affected individuals.

Also known as:

Key symptoms:

Underdeveloped cheekbonesSmall or underdeveloped upper jawAbnormally small eyesEyelid abnormalities such as drooping or narrowingFacial asymmetrySmall or recessed chinDental abnormalities or missing teethFlattened midfaceOblique or slanted eye openingsPossible vision problemsPossible hearing difficultiesCleft palate or high-arched palate

Clinical phenotype terms (21)— hover any for plain English
Tessier cleftHP:0002006Sparse or absent eyelashesHP:0200102Aplasia/Hypoplasia affecting the eyeHP:0008056
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Oculomaxillofacial dysostosis.

View clinical trials →

No actively recruiting trials found for Oculomaxillofacial dysostosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Oculomaxillofacial dysostosis community →

No specialists are currently listed for Oculomaxillofacial dysostosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Oculomaxillofacial dysostosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Oculomaxillofacial dysostosisForum →

No community posts yet. Be the first to share your experience with Oculomaxillofacial dysostosis.

Start the conversation →

Latest news about Oculomaxillofacial dysostosis

No recent news articles for Oculomaxillofacial dysostosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe are the facial bone and eye abnormalities in my child's case?,What surgeries or procedures might be needed, and at what ages?,How will this condition affect my child's vision, and what monitoring is needed?,Should we pursue genetic testing to look for an underlying cause?,Are there any breathing or feeding concerns we should watch for?,What therapies (speech, dental, psychological) would benefit my child?,Can you connect us with other families or support groups for craniofacial conditions?

Common questions about Oculomaxillofacial dysostosis

What is Oculomaxillofacial dysostosis?

Oculomaxillofacial dysostosis, also known as oculo-maxillo-facial dysostosis or sometimes referred to in relation to similar conditions as a craniofacial dysostosis, is an extremely rare congenital condition that affects the development of the bones and structures of the face, eyes, and jaw. The condition is present at birth and involves abnormal formation of the bones around the eyes (orbital area), the upper jaw (maxilla), and other facial structures. Key features typically include underdevelopment of the cheekbones and upper jaw, abnormalities of the eyes such as small eyes (microphthalmia)

At what age does Oculomaxillofacial dysostosis typically begin?

Typical onset of Oculomaxillofacial dysostosis is neonatal. Age of onset can vary across affected individuals.